In a press release dated September 29, 2009, Hard To Treat Diseases (PK:HTDS) announced that their China-based subsidiary, Mellow Hope, is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for international marketing and sales.

This was especially good news for HTDS investors. Zhejiang Tianyuan, according to the press release, had been granted an H1n1 [manufacturing] license on September 24, 2009 by the State Food and Drug Administration (SFDA) of the People's Republ... Read More

1 comments View Entry

SHENZHEN, China, Sept. 29 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com (HTDS) The issuer's China based operating subsidiary Mellow Hope through its exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd has been granted H1n1 license on September 24, 2009 by SFDA (China Authority) http://eng.sfda.gov.cn/eng. Mellow Hope is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales

Today, the issuer completed a set of... Read More

1 comments View Entry